JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2006, 55(1):4-11

Natural Polymers in the Formulation of Hydrophilic Matrix Tablets

M. Sedláková1, M. Rabišková1, J. Spilková2
1 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav technologie léků
2 Univerzita Karlova v Praze, Farmaceutická fakulta Hradec Králové, Katedra farmakognozie

Semisynthetic and synthetic polymers have found their use in the technology of hydrophilic matrix systems with controlled release of the active ingredient, in particular in oral administration. In the recent period, there is increased interest also in natural polymeric substances, whose advantage consists in safety, easy availability, and a relatively low price. They thus represent an interesting possibility to extend the selection of novel constitutive auxiliary substances. The present review paper surveys the most important natural polymers: alginans, carageens, Arabic gum, pectins, galactomanans, ispaghul, and xantan gum as potential carriers for oral hydrophilic systems with controlled release of active ingredients and describes its origin, properties, and possible uses in pharmacy.

Keywords: natural polymers; carriers; hydrophilic matrix tablets; controlled release of drugs

Received: June 10, 2005; Accepted: September 7, 2005; Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sedláková M, Rabišková M, Spilková J. Natural Polymers in the Formulation of Hydrophilic Matrix Tablets. Čes. slov. farm. 2006;55(1):4-11.
Download citation

References

  1. Bhardwaj, T. R., Kanwar, M., Lal, R., Gupta, A.: Drug. Dev. Ind. Pharm., 2000; 26, 1025-1038. Go to original source... Go to PubMed...
  2. Chalupová, Z., Masteiková, R., Savickas, A.: Čes. slov. Farm., 2005; 54, 55-59.
  3. Thombre, A. G., Cardinal, J. R.: In: Encyclopedia of Pharmaceutical Technology, Vol. 6 (Swarbrick, J., Boylan, J. C., ed.), New York and Basel, Marcel Dekker Inc., 1993, s. 61-69.
  4. Goñi, I., Ferrero, M. C., Jiménez-Castellanos, R. M., Gurruchaga, M.: Drug. Dev. Ind. Pharm., 2002; 28, 1101-1115. Go to original source... Go to PubMed...
  5. Vitková, M., Chalabala, M.: Acta Pharmaceutica Hungarica, 1998; 68, 336-344.
  6. Masteiková, R., Chalupová, Z., Šklubalová, Z.: Medicina, 2003; 39, 19-24.
  7. Giunchedi, P., Gavini, E., Moretti, M. D. L., Pirisino, G.: AAPS Pharm. Sci. Tech., 2002; 3, article 19.
  8. Draget, K. I., Smidsrød, O., Skjak-Braek, G.: In: Biopolymers, Vol. 2 (Steinbüchel, A., ed.), Weinheim, WileyVCH 2003, s. 216-225.
  9. FMC BioPolymer, Philadelphia: FMC Alginates, 2004, 9 s.
  10. Tønnesen, H. H., Karlsen, J.: Drug. Dev. Ind. Pharm., 2002; 28, 621-630. Go to original source... Go to PubMed...
  11. Klech, C. M.: In: Encyclopedia of Pharmaceutical Technology, Vol. 6. (Swarbrick, J., Boylan, J. C., ed.), New York and Basel, Marcel Dekker Inc., 1993, s. 415-440.
  12. Tapia, C., Costa, E., Moris, M. et al.: Drug. Dev. Ind. Pharm., 2002; 28, 217-224. Go to original source... Go to PubMed...
  13. Efentakis, M., Buckton, G.: Pharm. Dev. Technol., 2002; 7, 69-77. Go to original source... Go to PubMed...
  14. Wade, A., Weller, D. J.: Handbook of pharmaceutical excipients. 2. ed. London, The Pharmaceutical Press 1994, 651 s.
  15. Ahuja, A., Khar, R. K., Ali, J.: Drug. Dev. Ind. Pharm., 1997; 23, 489-515. Go to original source...
  16. Zeng, W. M.: Drug. Dev. Ind. Pharm., 2004; 30, 491-495. Go to original source... Go to PubMed...
  17. Bayomi, M. A., Al-Suwayeh, S. A., El-Helw, A.-R. M.: Drug. Dev. Ind. Pharm., 2001; 27, 499-506. Go to original source... Go to PubMed...
  18. van de Velde, F., De Ruiter, G. A.: In: Biopolymers, Vol. 2. (Steinbüchel, A., ed.), Weinheim, Wiley-VCH 2003, s. 247-272.
  19. Picker, K. M.: Drug. Dev. Ind. Pharm., 1999; 25, 329-337. Go to original source... Go to PubMed...
  20. Gupta, V. K., Hariharan, M., Wheatley, T. A., Price, J. C.: Eur. J. Pharm. Biopharm., 2001; 51, 241-248. Go to original source... Go to PubMed...
  21. FMC BioPolymer, Philadelphia: FMC Marine colloids - Carrageenan, 2004, 8 s.
  22. Picker, K. M.: Drug. Dev. Ind. Pharm., 1999; 25, 339-346. Go to original source... Go to PubMed...
  23. Bruneton, J.: Pharmacognosy, 2 ed. Paris, Lavoisier Publ. 1999, 61-87.
  24. Willy Benecke GmbH, Hamburg: Gum arabic, 2004, 3 s.
  25. Herbstreith Fox KG, Neuenbürg/Württ: Influence of calcium concentration on texture and baking stability of baking stable fruit preparations, 2004, 4 s.
  26. Sriamornsak, P.: Eur. J. Pharm. Sci., 1999; 8, 221-227. Go to original source... Go to PubMed...
  27. Sungthongjeen, S., Sriamornsak, P., Pitaksuteepong, T. et al.: AAPS Pharm. Sci. Tech., 2004; 5, article 9. Go to original source... Go to PubMed...
  28. Ahrabi, S. F., Madsen, G., Dyrstad, K. et al.:: Eur. J. Pharm. Sci., 2000; 10, 43-52. Go to original source... Go to PubMed...
  29. Herbstreith Fox KG, Neuenbürg/Württ: Diverse textures from different pectins, 2004, 8 s.
  30. Sungthongjeen, S., Pitaksuteepong, T., Somsiri, A., Sriamornsak, P.: Drug. Dev. Ind. Pharm., 1999; 25, 1271-1276. Go to original source... Go to PubMed...
  31. Hiort, M., Tho, I., Sande, S. A.: Eur. J. Pharm. Biopharm., 2003; 56, 175-182.
  32. Murata, Y., Sasaki, N., Miyamoto, E., Kawashima, S.: Eur. J. Pharm. Biopharm., 2000; 50, 221-226. Go to original source... Go to PubMed...
  33. AG Altrafine Gums, Gujarat: Guar gum information, 2004, 4 s.
  34. Shree Ram, Jodhpur: Guar gum splits, 2004, 5 s.
  35. Krishnaiah, Y. S. R., Satyanarayana, V., Kumar, B. D., Karthikeyan, R. S.: Eur. J. Pharm. Sci., 2002; 16, 185-192. Go to original source... Go to PubMed...
  36. Willy Benecke GmbH, Hamburg: Guar gum, 2004, 2 s.
  37. Khullar, P., Khar, R. K., Agarwal, S. P.: Drug. Dev. Ind. Pharm., 1998; 24, 1095-1099. Go to original source... Go to PubMed...
  38. Gohel, M. C., Panchal, M. K.: Drug. Dev. Ind. Pharm., 2002; 28, 77-87. Go to original source... Go to PubMed...
  39. Megamic Globus Est., Mumbai: Psyllium products, 2004, 4 s.
  40. Gohel, M. C., Patel, K. V.: Drug. Dev. Ind. Pharm., 1997; 23, 1055-1061. Go to original source...
  41. Gowthaman, M. K., Prasad, M. S., Karanth, N. G.: In: Encyclopedia of Food Microbiology, Vol. 2. (Perlman, D., ed.) New York, Academic Press 1999, s. 265-271.
  42. Born, K., Langendorff, V., Boulenguer, P.: In: Biopolymers, Vol. 3. (Steinbüchel, A., ed.) Weinheim, WileyVCH 2003, s. 261-292.
  43. El-Gazayerly, O. N.: Drug. Dev. Ind. Pharm., 2003; 29, 241-246. Go to original source... Go to PubMed...
  44. Billa, N., Yuen, K.-H.: AAPS Pharm. Sci. Tech., 2000; 1, article 30. Go to original source... Go to PubMed...
  45. Park, C. R., Munday, D. L.: Drug. Dev. Ind. Pharm., 2004; 30, 609-617. Go to original source... Go to PubMed...
  46. Talukdar, M., Kinget, R.: Int. J. Pharm., 1997; 151, 99-107. Go to original source...
  47. Talukdar, M., Michoel, A., Rombaut, P., Kinget, R.: Int. J. Pharm., 1996; 129, 233-241. Go to original source...
  48. Santos, H., Veiga, F., Pina, E., Sousa, J. J.: Eur. J. Pharm. Sci., 2004; 21, 271-281. Go to original source... Go to PubMed...
  49. Dürig, T., Fassihi, R.: J. Control. Rel., 2002; 80, 45-56. Go to original source... Go to PubMed...
  50. Bayomi, M. A., Al-Suwayeh, S. A., El-Helw, A.-R.: Drug Dev. Ind. Pharm., 2001; 27, 499-506. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.